A novel orthotopic mouse model of head and neck cancer and lymph node metastasis

Oncogenesis

Volumn 2, Issue , 2013, Pages

  Masood, R ^a   Hochstim, C ^a   Cervenka, B ^a   Zu, S ^a   Baniwal, S K ^a   Patel, V ^b   Kobielak, A ^a   Sinha, U K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Cancer stem cells (CSCs); Epithelial to mesenchymal transition (EMT); Head and neck squamous cell carcinoma genetics; Metastasis

Indexed keywords

CAVEOLIN 1; MATRILYSIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PROTEIN ALDH1A3; PROTEIN TRIM 29; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC ASSOCIATION; HEAD AND NECK CANCER; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; MOUSE; NECK METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84884800205     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2013.33     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733-744. (Pubitemid 37328812)
3. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (New York, NY) 2011; 333: 1154-1157.
4. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A et al. The mutational landscape of head and neck squamous cell carcinoma. Science (New York, NY) 2011; 333: 1157-1160.
5. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636. (Pubitemid 46631302)
6. Zhang X, Su L, Pirani AA, Wu H, Zhang H, Shin DM et al. Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis. Clin Exp Metastasis 2006; 23: 209-222. (Pubitemid 44673810)
7. Vermorken JB, Herbst RS, Leon X, Amellal N, Baselga J. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies. Cancer 2008; 112: 2710-2719. (Pubitemid 351969215)
8. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784. (Pubitemid 38063698)
9. Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011; 112: 2508-2517.
10. Zhang Z, Filho MS, Nor JE. The biology of head and neck cancer stem cells. Oral Oncol 2012; 48: 1-9.
11. Chute JP, Muramoto GG, Whitesides J, Colvin M, Safi R, Chao NJ et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103: 11707-11712. (Pubitemid 44182515)
12. Sano D, Myers JN. Xenograft models of head and neck cancers. Head Neck Oncol 2009; 1: 32.
13. Yigitbasi OG, Younes MN, Doan D, Jasser SA, Schiff BA, Bucana CD et al. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Cancer Res 2004; 64: 7977-7984. (Pubitemid 39446932)
14. Liebertz DJ, Lechner MG, Masood R, Sinha UK, Han J, Puri RK et al. Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1. Head Neck Oncol 2010; 2: 5.
15. Goldberg HI, Lockwood SA, Wyatt SW, Crossett LS. Trends and differentials in mortality from cancers of the oral cavity and pharynx in the United States, 1973-1987. Cancer 1994; 74: 565-572. (Pubitemid 24217618)
16. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002; 95: 1663-1672.
17. Rosano L, Cianfrocca R, Spinella F, Di Castro V, Nicotra MR, Lucidi A et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res 2011; 17: 2350-2360.
18. Siu A, Lee C, Dang D, Lee C, Ramos DM. Stem cell markers as predictors of oral cancer invasion. Anticancer Res 2012; 32: 1163-1166.
19. Lo WL, Chien Y, Chiou GY, Tseng LM, Hsu HS, Chang YL et al. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells. Biomaterials 2012; 33: 3693-3709.
20. Marcato P, Dean CA, Giacomantonio CA, Lee PW. Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle (Georgetown, Tex) 2011; 10: 1378-1384.
21. Luo Y, Dallaglio K, Chen Y, Robinson WA, Robinson SE, McCarter MD et al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem cells (Dayton, Ohio) 2012; 30: 2100-2113.
22. Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. Cancer Cell 2009; 15: 207-219.
23. Zhou ZY, Yang GY, Zhou J, Yu MH. Significance of TRIM29 and beta-catenin expression in non-small-cell lung cancer. J Chin Med Assoc 2012; 75: 269-274.
24. Hung KF, Lin SC, Liu CJ, Chang CS, Chang KW, Kao SY. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 2003; 32: 461-467.
25. Xue J, Chen H, Diao L, Chen X, Xia D. Expression of caveolin-1 in tongue squamous cell carcinoma by quantum dots. Eur J Histochem 2010; 54: e20.
26. Zhao X, Ma C, Cai X, Lei D, Liu D, Xu F et al. RNA interference of caveolin-1 via lentiviral vector inhibits growth of hypopharyngeal squamous cell carcinoma FaDu cells In Vitro and In Vivo. Asian Pac J Cancer Prev 2011; 12: 397-401.
27. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003; 4: 499-515. (Pubitemid 38050046)
28. Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 2003; 23: 1197-1203. (Pubitemid 36871273)
29. Szczepanski MJ, Czystowska M, Szajnik M, Harasymczuk M, Boyiadzis M, Kruk-Zagajewska A et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res. 2009; 69: 3105-3113.
30. Jing YY, Han ZP, Sun K, Zhang SS, Hou J, Liu Y et al. Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med 2012; 10: 98.
31. Machida K, Chen CL, Liu JC, Kashiwabara C, Feldman D, French SW et al. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus. J Gastroenterol Hepatol 2012; 27(Suppl 2): 19-22.
32. Chang CJ, Chien Y, Lu KH, Chang SC, Chou YC, Huang CS et al. Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun 2011; 415: 245-251.
33. Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Chang SC et al. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011; 141: 279-291.
34. Wang WS, Chen PM, Wang HS, Liang WY, Su Y. Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis 2006; 27: 1113-1120.
35. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase- 7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 2006; 231: 20-27. (Pubitemid 43063974)
36. Shibata S, Marushima H, Asakura T, Matsuura T, Eda H, Aoki K et al. Threedimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Int J Oncol 2009; 34: 1433-1448.